Fonseka C, Rao D, Raychaudhuri S
Curr Opin Immunol. 2017; 49:27-36.
PMID: 28888129
PMC: 5705469.
DOI: 10.1016/j.coi.2017.08.005.
Sargent A, Miller R
Curr Stem Cell Rep. 2017; 2(2):168-173.
PMID: 28133600
PMC: 5267490.
DOI: 10.1007/s40778-016-0044-6.
Orent W, Mchenry A, Rao D, White C, Klein H, Bassil R
Hum Mol Genet. 2015; 25(2):404-17.
PMID: 26604133
PMC: 4881829.
DOI: 10.1093/hmg/ddv474.
Pinz K, Liu H, Golightly M, Jares A, Lan F, Zieve G
Leukemia. 2015; 30(3):701-7.
PMID: 26526988
DOI: 10.1038/leu.2015.311.
Walter G, Fleskens V, Frederiksen K, Rajasekhar M, Menon B, Gerwien J
Arthritis Rheumatol. 2015; 68(1):103-16.
PMID: 26314565
PMC: 4832388.
DOI: 10.1002/art.39408.
Immune cell profiling to guide therapeutic decisions in rheumatic diseases.
Ermann J, Rao D, Teslovich N, Brenner M, Raychaudhuri S
Nat Rev Rheumatol. 2015; 11(9):541-51.
PMID: 26034835
PMC: 4898649.
DOI: 10.1038/nrrheum.2015.71.
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments.
Scheerens H, Su Z, Irving B, Townsend M, Zheng Y, Stefanich E
Arthritis Res Ther. 2011; 13(5):R177.
PMID: 22029963
PMC: 3308112.
DOI: 10.1186/ar3502.
Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.
Manikwar P, Kiptoo P, Badawi A, Buyuktimkin B, Siahaan T
Med Res Rev. 2011; 32(4):727-64.
PMID: 21433035
PMC: 4441537.
DOI: 10.1002/med.20243.
Mechanisms of lymphocyte adhesion to endothelial cells: studies using a LFA-1-deficient cell line.
Haskard D, Strobel S, Thornhill M, Pitzalis C, Levinsky R
Immunology. 1989; 66(1):111-6.
PMID: 15493272
PMC: 1385129.
Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation.
Pohlers D, Nissler K, Frey O, Simon J, Petrow P, Kinne R
Clin Exp Immunol. 2004; 135(3):409-15.
PMID: 15008972
PMC: 1808984.
DOI: 10.1111/j.1365-2249.2003.02381.x.
Impaired autologous mixed lymphocyte reaction (AMLR) reactivity of peripheral blood T cell subsets in rheumatoid arthritis.
Keystone E, Poplonski L, Snow K, Martell M
Clin Exp Immunol. 1989; 78(2):184-8.
PMID: 12412746
PMC: 1534674.
Tumour necrosis factor-alpha (TNF-alpha) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice.
Wahid S, Blades M, De Lord D, Brown I, Blake G, Yanni G
Clin Exp Immunol. 2000; 122(1):133-42.
PMID: 11012629
PMC: 1905754.
DOI: 10.1046/j.1365-2249.2000.01342.x.
The role of T cells in rheumatoid arthritis.
de Keyser F, Elewaut D, Vermeersch J, De Wever N, Cuvelier C, Veys E
Clin Rheumatol. 1995; 14 Suppl 2:5-9.
PMID: 8846654
DOI: 10.1007/BF02215850.
The bacterial superantigen Staphylococcal enterotoxin B stimulates lymphocyte locomotor capacity during culture in vitro.
NEWMAN I, Wilkinson P
Immunology. 1996; 87(3):428-33.
PMID: 8778029
PMC: 1384112.
DOI: 10.1046/j.1365-2567.1996.491565.x.
Chondrocyte-peripheral blood mononuclear cell interactions: the role of ICAM-1.
Horner A, Davies M, Franz B
Immunology. 1995; 86(4):584-90.
PMID: 8567025
PMC: 1384059.
The effect of auranofin and sulphasalazine therapy on circulating levels of interleukin 6 in rheumatoid arthritis patients.
Crilly A, Capell H, Watson J, Madhok R
Clin Rheumatol. 1995; 14(5):561-5.
PMID: 8549096
DOI: 10.1007/BF02208155.
Locomotor responses of human CD45 lymphocyte subsets: preferential locomotion of CD45RO+ lymphocytes in response to attractants and mitogens.
NEWMAN I, Wilkinson P
Immunology. 1993; 78(1):92-8.
PMID: 8436407
PMC: 1421773.
A high proportion of the V delta 1+ synovial fluid gamma delta T cells in juvenile rheumatoid arthritis patients express the very early activation marker CD69, but carry the high molecular weight isoform of the leucocyte common antigen (CD45RA).
Kjeldsen-Kragh J, Quayle A, Vinje O, Natvig J, Forre O
Clin Exp Immunol. 1993; 91(2):202-6.
PMID: 8428387
PMC: 1554688.
DOI: 10.1111/j.1365-2249.1993.tb05883.x.
Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature.
Elices M, Tsai V, Strahl D, Goel A, Tollefson V, Arrhenius T
J Clin Invest. 1994; 93(1):405-16.
PMID: 8282813
PMC: 293796.
DOI: 10.1172/JCI116975.
T cell repertoire and autoimmune diseases.
Imberti L, Sottini A, Primi D
Immunol Res. 1993; 12(2):149-67.
PMID: 8254224
DOI: 10.1007/BF02918301.